Skip to Content
Merck
CN

SML3863

Tecovirimat

≥98% (HPLC)

Synonym(s):

4-Trifluoromethyl-N-(3,3a,4,4a,5,5a,6,6a-octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl)-benzamide, SIGA-246, ST-246, rel-N-[(3aR,4R,4aR,5aS,6S,6aS)-3,3a,4,4a,5,5a,6,6a-Octahydro-1,3-dioxo-4,6-ethenocycloprop[f]isoindol-2(1H)-yl]-4-(trifluoromethyl)benzamide

Sign In to View Organizational & Contract Pricing.

Select a Size


About This Item

Empirical Formula (Hill Notation):
C19H15F3N2O3
CAS Number:
Molecular Weight:
376.33
NACRES:
NA.77
Assay:
≥98% (HPLC)
Form:
powder
Quality level:
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

assay

≥98% (HPLC)

form

powder

color

white to beige

solubility

DMSO: 2 mg/mL, clear

storage temp.

-10 to -25°C

Quality Level

Biochem/physiol Actions

Antiviral with activity against orthopoxviruses such as cowpox and monkeypox and including smallpox
Tecovirimat (ST-246) is an antiviral with activity against orthopoxviruses such as cowpox and monkeypox and including smallpox. Tecovirimat inhibits the function of a major envelope protein required for the production of extracellar virus, prevented the virus from leaving the cell, and spreading within the body. FDA-approved for the treatment of human smallpox disease caused by Variola virus in adults and children.

Disclaimer

Research use only, not for use in humans.

Storage Class

11 - Combustible Solids

wgk

WGK 3

flash_point_f

Not applicable

flash_point_c

Not applicable


Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

Don't see the Right Version?

If you require a particular version, you can look up a specific certificate by the Lot or Batch number.

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library

Efficacy of tecovirimat (ST-246) in nonhuman primates infected with variola virus (Smallpox)
Antimicrobial Agents and Chemotherapy, 57(12), 6246-6253 (2013)
Emergence of cowpox: study of the virulence of clinical strains and evaluation of antivirals
PLoS ONE, 8(2), e55808-e55808 (2013)
Fragment-Based Approaches Identified Tecovirimat-Competitive Novel Drug Candidate for Targeting the F13 Protein of the Monkeypox Virus
Viruses, 15(2), 570-570 (2023)

Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.

Contact Technical Service